USP22 Is Useful as a Novel Molecular Marker for Predicting Disease Progression and Patient Prognosis of Oral Squamous Cell Carcinoma
Open Access
- 3 August 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (8), e42540
- https://doi.org/10.1371/journal.pone.0042540
Abstract
The significance of ubiquitin-specific protease 22 (USP22) as a potential marker has been growing in the field of oncology. The aim of this study was to investigate the role of USP22 and the association with its potential targets in oral squamous cell carcinoma (OSCC). Immunohistochemistry was used to determine the expression of USP22 protein in 319 OSCC patients in comparison with 42 healthy controls. The clinical correlations and prognostic significance of the aberrantly expressed protein was evaluated to identify novel biomarker of OSCC. The incidence of positive USP22 expression was 63.32% in 319 conventional OSCC tissues. The protein expression level of USP22 was concomitantly up-regulated from non-cancerous mucosa to primary carcinoma and from carcinomas to lymph node metastasis (PPP<0.001, respectively). Cancer cells with reduced USP22 expression exhibited reduced proliferation and colony formation evaluated by MTT and soft agar assays. To our knowledge, this is the first study that determines the relationship between USP22 expression and prognosis in OSCC. We found that increased expression of USP22 is associated with poor prognosis in OSCC. USP22 may represent a novel and useful prognostic marker for OSCC.Keywords
This publication has 25 references indexed in Scilit:
- Over-Expression of LSD1 Promotes Proliferation, Migration and Invasion in Non-Small Cell Lung CancerPLOS ONE, 2012
- NAHA, a Novel Hydroxamic Acid-Derivative, Inhibits Growth and Angiogenesis of Breast Cancer In Vitro and In VivoPLOS ONE, 2012
- Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancerJournal of Surgical Oncology, 2010
- “Stemness” Genomics Law Governs Clinical Behavior of Human Cancer: Implications for Decision Making in Disease ManagementJournal of Clinical Oncology, 2008
- Dubbing SAGA Unveils New Epigenetic CrosstalkMolecular Cell, 2008
- A TFTC/STAGA Module Mediates Histone H2A and H2B Deubiquitination, Coactivates Nuclear Receptors, and Counteracts Heterochromatin SilencingMolecular Cell, 2008
- The Putative Cancer Stem Cell Marker USP22 Is a Subunit of the Human SAGA Complex Required for Activated Transcription and Cell-Cycle ProgressionMolecular Cell, 2008
- The SAGA continues: expanding the cellular role of a transcriptional co-activator complexOncogene, 2007
- Multi-tasking on chromatin with the SAGA coactivator complexesMutation Research, 2007
- Genomic Models of Metastatic Cancer: Functional Analysis of Death-from-Cancer Signature Genes Reveals Aneuploid, Anoikis-Resistant, Metastasis-Enabling Phenotype with Altered Cell Cycle Control and Activated PcG Protein Chromatin Silencing PathwayCell Cycle, 2006